首页 | 本学科首页   官方微博 | 高级检索  
检索        

骨肿瘤复发后组织起源及p53.C—erbB—2表达的变化
引用本文:于秀淳,刘晓平.骨肿瘤复发后组织起源及p53.C—erbB—2表达的变化[J].中国矫形外科杂志,1999,6(5):356-357.
作者姓名:于秀淳  刘晓平
作者单位:济南军区总医院骨病科
摘    要:目的:探讨骨肿瘤复发后组织起源及相关癌基因蛋白表达的变化。方法:应用免疫组化方法,测定8例骨肿瘤复发前后16个标本Vimentin.Actin.p53C-erbB-2蛋白的表达。良性骨肿瘤2例,恶性骨肿瘤6例。结果:2例良性骨肿瘤在复发前后各项指标均无变化;6例恶性骨肿瘤中,3例Vimentin,5例Actin,3例p53和2例C-erbB-2基因在复发前后表达结果不同。结论:复发恶性骨肿瘤与原发可能并非同源,体内存在另外的致癌因素,使癌基因发生改变,导致肿瘤再生。

关 键 词:骨肿瘤  复发  癌基因  免疫组化

Changes in Histogenesis and Expressions of P53,C-erbB-2 in Recurrence Bone Tumor
Yu Xiuchun,Liu Xiaoping,Zhou Yin,et al..Changes in Histogenesis and Expressions of P53,C-erbB-2 in Recurrence Bone Tumor[J].The Orthopedic Journal of China,1999,6(5):356-357.
Authors:Yu Xiuchun  Liu Xiaoping  Zhou Yin  
Institution:Yu Xiuchun,Liu Xiaoping,Zhou Yin,et al.Department of Orthopaedics,Jinan Military General Hospital.Jinan 250031.
Abstract:Objective:To investigate the changes in histogenesis and expressions of related oncogene protein in recurrent bone tumor.Methods:The expressions of Vimentin,Actin,P53,C-erbB-2 of 16 samples from 8 cases of recurrent bone tumor were determined by immunohistochemisty.There were 2 in benign and 6 in malignant.Results:There were no change of every singles in primary and recurrent benign bone tumor;in 6 malignant tumor,there were different expressions in primary and recurrent of Vimentin in 3 cases,Actin in 5 cases,P53 in 3 cases and C-erbB-2 in 2 cases.Conclusion:The histogenesis of recurrent malignant bone tumor might be different from that of the primary and there were other causing cancer factors in human body,and made other oncogene change,led to the tumor recurrence.
Keywords:Bone tumor  Recurrence  Oncogene  Immunohistochemistry  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号